Effects of interleukin-37 on cardiac function after myocardial infarction in mice

International Journal of Clinical and Experimental Pathology

Volumn 8, Issue 5, 2015, Pages 5247-5251

  Xu, Daoying ^a   Wang, Aiqin ^a   Jiang, Fengqin ^a   Hu, Junhong ^a   Zhang, Xiuzhou ^a  

^a Binzhou People's Hospital   (China)

Author keywords

Cardiac function; Inflammation; Interleukin 37; Myocardial infarction

Indexed keywords

ANTIINFLAMMATORY AGENT; AUTACOID; CARDIOTONIC AGENT; INTERLEUKIN 1; PEROXIDASE; RELA PROTEIN, MOUSE; TRANSCRIPTION FACTOR RELA;

ANIMAL; C57BL MOUSE; CARDIAC MUSCLE; DIAGNOSTIC IMAGING; DISEASE MODEL; DRUG EFFECTS; ECHOGRAPHY; HEART LEFT VENTRICLE FUNCTION; HEART STROKE VOLUME; MALE; METABOLISM; MYOCARDIAL INFARCTION; PATHOPHYSIOLOGY; PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CARDIOTONIC AGENTS; DISEASE MODELS, ANIMAL; INFLAMMATION MEDIATORS; INTERLEUKIN-1; MALE; MICE, INBRED C57BL; MYOCARDIAL INFARCTION; MYOCARDIUM; PEROXIDASE; PHOSPHORYLATION; SIGNAL TRANSDUCTION; STROKE VOLUME; TRANSCRIPTION FACTOR RELA; ULTRASONOGRAPHY; VENTRICULAR FUNCTION, LEFT;

EID: 84937869992     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Tete S, Tripodi D, Rosati M, Conti F, Maccauro G, Saggini A, Cianchetti E, Caraffa A, Antinolfi P, Toniato E, Castellani ML, Conti P, Theoharides TC. IL-37 (IL-1F7) the newest anti-inflammatory cytokine which suppresses immune responses and inflammation. Int J Immunopathol Pharmacol 2012; 25: 31-38.
2. Nold MF, Nold-Petry CA, Zepp JA, Palmer BE, Bufler P, Dinarello CA. IL-37 is a fundamental inhibitor of innate immunity. Nat Immunol 2010; 11: 1014-1022.
3. Bufler P, Gamboni-Robertson F, Azam T, Kim SH, Dinarello CA. Interleukin-1 homologues IL-1F7b and IL-18 contain functional mRNA instability elements within the coding region responsive to lipopolysaccharide. Biochem J 2004; 381: 503-510.
4. Sakai N, Van Sweringen HL, Belizaire RM, Quillin RC, Schuster R, Blanchard J, Burns JM, Tevar AD, Edwards MJ, Lentsch AB. Interleukin-37 reduces liver inflammatory injury via effects on hepatocytes and non-parenchymal cells. J Gastroenterol Hepatol 2012; 27: 1609-1616.
5. Ji Q, Zeng Q, Huang Y, Shi Y, Lin Y, Lu Z, Meng K, Wu B, Yu K, Chai M, Liu Y, Zhou Y. Elevated plasma IL-37, IL-18, and IL-18BP concentrations in patients with acute coronary syndrome. Mediators Inflamm 2014; 2014: 165742.
6. Kain V, Prabhu SD, Halade GV. Inflammation revisited: inflammation versus resolution of inflammation following myocardial infarction. Basic Res Cardiol 2014; 109: 444.
7. Seaman DR, Palombo AD. An overview of the identification and management of the metabolic syndrome in chiropractic practice. J Chiropr Med 2014; 13: 210-219.
8. Shukla SK, Sharma SB, Singh UR. Pre-treatment with alpha-tocopherol and Termi-nalia arjuna ameliorates, markers of inflammation, cardiac and apoptotic markers in experimental myocardial ischemic rats. Redox Rep 2015; 20: 49-59.
9. Wei N, Zhang C, He H, Wang T, Liu Z, Liu G, Sun Z, Zhou Z, Bai C, Yuan D. Protective effect of saponins extract from Panax japonicus on myocardial infarction: involvement of NF-kappaB, Sirt1 and mitogen-activated protein kinase signalling pathways and inhibition of inflammation. J Pharm Pharmacol 2014; 66: 1641-51.
10. De Hoog VC, Timmers L, Van Duijvenvoorde A, De Jager SC, Van Middelaar BJ, Smeets MB, Woodruff TM, Doevendans PA, Pasterkamp G, Hack CE, De Kleijn DP. Leucocyte expression of complement C5a receptors exacerbates infarct size after myocardial reperfusion injury. Cardiovasc Res 2014; 103: 521-529.
11. Lin J, Wang H, Li J, Wang Q, Zhang S, Feng N, Fan R, Pei J. kappa-Opioid receptor stimulation modulates TLR4/NF-kappaB signaling in the rat heart subjected to ischemia-reperfusion. Cytokine 2013; 61: 842-848.
12. Li TT, Zhang YS, He L, Liu B, Shi RZ, Zhang GG, Peng J. Inhibition of vascular peroxidase alleviates cardiac dysfunction and apoptosis induced by ischemia-reperfusion. Can J Physiol Pharmacol 2012; 90: 851-862.
13. Pazur JH, Kelly-Delcourt SA, Miskiel FJ, Burdett L, Docherty JJ. The isolation of anti-gum arabic antibodies by affinity chromatography. J Immunol Methods 1986; 89: 19-25.
14. Halade GV, Ma Y, Ramirez TA, Zhang J, Dai Q, Hensler JG, Lopez EF, Ghasemi O, Jin YF, Lindsey ML. Reduced BDNF attenuates inflammation and angiogenesis to improve survival and cardiac function following myocardial infarction in mice. Am J Physiol Heart Circ Physiol 2013; 305: H1830-1842.
15. Vasilj M, Starcevic B, Volaric M, Jelavic B, Leventic M, Cuk D, Coric S. Diagnostic value of MPO in patients admitted for suspected acute coronary syndrome-a study of adult in Mostar, Bosnia and Herzegovina. Coll Antropol 2014; 38: 213-217.
16. Liu C, Xie G, Huang W, Yang Y, Li P, Tu Z. Elevated serum myeloperoxidase activities are significantly associated with the prevalence of ACS and High LDL-C levels in CHD patients. J Atheroscler Thromb 2012; 19: 435-443.
17. Zhang XQ, Tang R, Li L, Szucsik A, Javan H, Saegusa N, Spitzer KW, Selzman CH. Cardiomyocyte-specific p65 NF-kappaB deletion protects the injured heart by preservation of calcium handling. Am J Physiol Heart Circ Physiol 2013; 305: H1089-1097.
18. Zeng M, Wei X, Wu Z, Li W, Li B, Zhen Y, Chen J, Wang P, Fei Y. NF-kappaB-mediated induction of autophagy in cardiac ischemia/reperfusion injury. Biochem Biophys Res Commun 2013; 436: 180-185.
19. Zhang S, Liu X, Goldstein S, Li Y, Ge J, He B, Fei X, Wang Z, Ruiz G. Role of the JAK/STAT signaling pathway in the pathogenesis of acute myocardial infarction in rats and its effect on NF-kappaB expression. Mol Med Rep 2013; 7: 93-98.
20. Hu WS, Lin YM, Ho TJ, Chen RJ, Li YH, Tsai FJ, Tsai CH, Day CH, Chen TS, Huang CY. Genistein suppresses the isoproterenol-treated H9c2 cardiomyoblast cell apoptosis associated with P-38, Erk1/2, JNK, and NFkappaB signaling protein activation. Am J Chin Med 2013; 41: 1125-1136.
21. Jenke A, Wilk S, Poller W, Eriksson U, Valaperti A, Rauch BH, Stroux A, Liu P, Schultheiss HP, Scheibenbogen C, Skurk C. Adiponectin protects against Toll-like receptor 4-mediated cardiac inflammation and injury. Cardiovasc Res 2013; 99: 422-431.
22. Fernandez-Velasco M, Prieto P, Terron V, Benito G, Flores JM, Delgado C, Zaragoza C, Lavin B, Gomez-Parrizas M, Lopez-Collazo E, Martin-Sanz P, Bosca L. NOD1 activation induces cardiac dysfunction and modulates cardiac fibrosis and cardiomyocyte apoptosis. PLoS One 2012; 7: e45260.
23. Chen ZW, Qian JY, Ma JY, Chang SF, Yun H, Jin H, Sun AJ, Zou YZ, Ge JB. TNF-alpha-induced cardiomyocyte apoptosis contributes to cardiac dysfunction after coronary microembolization in mini-pigs. J Cell Mol Med 2014; 18: 1953-63.
24. Tank J, Lindner D, Wang X, Stroux A, Gilke L, Gast M, Zietsch C, Skurk C, Scheibenbogen C, Klingel K, Lassner D, Kuhl U, Schultheiss HP, Westermann D, Poller W. Single-target RNA interference for the blockade of multiple interacting proinflammatory and profibrotic pathways in cardiac fibroblasts. J Mol Cell Cardiol 2014; 66: 141-156.